Rigel Pharmaceuticals
RIGL
RIGL
110 hedge funds and large institutions have $300M invested in Rigel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
52% less call options, than puts
Call options by funds: $579K | Put options by funds: $1.19M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
110
Holding in Top 10
–
Calls
$579K
Puts
$1.19M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$3.88M | |
| 3 | +$3.14M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$2.01M |
| 5 |
BC
Broadfin Capital
New York
|
+$1.94M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$5.48M | |
| 3 | -$3.95M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.81M |
| 5 |
Renaissance Technologies
New York
|
-$3.65M |